BioMimetic Therapeutics, Inc. to Highlight Corporate Activities at the Deutsche Bank 33rd Annual Health Care Conference

FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced today that Dr. Samuel E. Lynch, CEO and president, will provide an update of corporate activities at the Deutsche Bank 33rd Annual Health Care Conference. The presentation will take place in the Hutchinson Ballroom at the Intercontinental Hotel in Boston on Monday, May 5 at 2:00 p.m. EDT.
MORE ON THIS TOPIC